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On November 6, 2015, the Nutrition Risk SRP, participants from the JSC, HQ, and NRESS 
participated in a WebEx/teleconference.  The purpose of the call (as stated in the Statement of 
Task) was to allow the SRP members to: 
 
1. Receive an update from the HRP Chief Scientist (or designee) on the status of NASA’s 
current and future exploration plans and the impact these will have on the HRP. 
2. Receive an update on any changes within the HRP since the 2014 SRP meeting. 
3. Receive an update by the Element or Project Scientist(s) since the 2014 SRP meeting. 
4. Participate in a discussion with the HRP Chief Scientist (or designee) and the Element 
regarding possible topics to be addressed at the next SRP meeting 
 
Based on the presentations and the discussion during the WebEx/teleconference, the SRP would 
like to relay the following information to Dr. Shelhamer, the HRP Chief Scientist. 
 
The SRP thinks the research conducted in support of addressing the Risk of Inadequate Nutrition 
continues to be extremely productive and important to the successful completion of the closing 
of gaps in knowledge related to inadequate nutrition in low Earth orbit flights, as well as long 
duration spaceflight anticipated in the future.  Given the major increase in risk related to the 
proposed exploration of deep space, it is important to facilitate the gathering of as much data as 
possible in terms of blood and urine sampling and special testing that will foster a major increase 
in the quality of knowledge gained from a limited data set.  Given the ability to define the dietary 
inflammatory potential of normal food (an important factor in a space environment that is likely 
to markedly increase oxidative inflammation) as well insulinogenic effects (important in 
managing fluid retention) of the diet, the SRP thinks it will be important to explore this aspect of 
mitigation as well to continue their seminal work in the potential visual complications of 
spaceflight. 
 
The SRP would like to emphasize priority for the following initiatives that Dr. Smith presented 
during the WebEx/teleconference: 
1. The extended genetics study in relation to one carbon metabolism. 
2. The biochemical profile study including blood and urine samples.  The ability to measure 
serial blood samples to examine space-induced changes in various serum and urine-based 
parameters is a critical component of the nutrition research program. 
3. Investigations of mitigating radiation exposure /oxidative stress concerns with diet and 
supplement measures.  This is especially critical in view of the anticipated Mars missions 
and possible adverse impacts upon multiple key body functions. 
 
The SRP would also like to stress the importance of the ongoing research being conducted 
especially as it relates to the health of the astronauts.  The integrated nutrition program using 
standardized preparations of foods with potential antioxidant activity to protect against radiation 
injury is important as is the development of specific testing outcomes in regards to the eye, brain, 
bone, and vital organs.  Great progress has been made but additional support for this important 
work is critical to the success of the future long duration space travel being contemplated. 
 
The HRP’s seminal findings about visual complications of spaceflight were primarily enabled by 
the availability of reliable functional outcome measures, in this case ophthalmologic exam.  As 





other important potential nutrition risks are observed, the SRP thinks it will be equally important 
to make optimal use of functional/physiologic outcome measures in order to anchor both 
correlational and intervention studies.  Reliance of functional outcome measures and establishing 
a baseline for testing countermeasures appears to be part of HRP’s core philosophy and mandate 
for maximizing limited resources.  Newer functional metrics have been developed in recent years 
and could be of great value for the HRP to incorporate.  For example, the observation of 
increased white brain matter densities is of concern, and might be anchored functionally by new 
methods for monitoring myelin turnover from blood samples.  Similarly, changes in muscle 
mass, bone catabolism, immunology and chronic inflammation are increasingly amenable to 
minimally invasive monitoring in ground studies and in spaceflight. Evaluation of emerging 
technologies and metrics in these areas as outcome markers is worthy of attention. 
